Description
RiboGrip™ RNase Inhibitor is an in silico-designed protein-based ribonuclease inhibitor, which inactivates RNase A.
RiboGrip™ inhibits the activity of ribonuclease A by noncovalently binding in a non-competitive mode at a ratio of 1:1. This novel inhibitor has enhanced stability at room temperature with no loss of activity for up to 1 month.
Applications
Preventing RNA degradation in the following applications:
- First-strand cDNA synthesis
- RT-PCR
- RT-qPCR
- in vitro transcription and translation